Physician profile
Heather D Volkman
NPI 1932326253
$8,687.33
in general payments reported to CMS, 2019-2025
33 companies · $2,514 in 2025
The $2,514 reported for 2025 was more than what 77% of Pediatric Dermatology providers received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $766 · 2021: $375 · 2022: $777 · 2023: $1,148 · 2024: $2,153 · 2025: $2,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,785 · Education: $30.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,784.61 |
| Education | $30.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,858.42 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $707.45 | 2019-2025 | |
| Abbvie INC. | $696.01 | 2019-2025 | Skyrizi |
| Leo Pharma INC. | $635.46 | 2022-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $572.84 | 2022-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $452.35 | 2019-2025 | Dupixent |
| Janssen Biotech, INC. | $429.62 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Pfizer INC. | $422.57 | 2019-2025 | |
| Incyte Corporation | $414.22 | 2021-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $314.84 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $307.97 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $286.59 | 2019-2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $262.15 | 2019-2025 | Cabtreo |
| Amgen INC. | $173.67 | 2020-2025 | Otezla, Otezla |
| Almirall LLC | $173.55 | 2019-2025 | Klisyri |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $153.93 | 2023-2025 | Bimzelx |
| Verrica Pharmaceuticals INC. | $117.43 | 2023-2024 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.47 | 2022-2024 | Spevigo, Cyltezo |
| Sun Pharmaceutical Industries INC. | $112.12 | 2020-2022 | |
| Dermavant Sciences, INC. | $82.85 | 2023-2024 | Vtama |
| Glaxosmithkline, LLC. | $67.65 | 2019-2020 | |
| Dusa Pharmaceuticals, INC. | $57.05 | 2019 | |
| Nobelpharma America, LLC | $48.64 | 2024 | |
| Aclaris Therapeutics, INC. | $46.32 | 2019 | |
| Medimetriks Pharmaceuticals, INC. | $34.74 | 2025 | Neo-Synalar, Clindacin Etz |
| Krystal Biotech INC | $25.28 | 2024 | Vyjuvek |
| Blueprint Medicines Corporation | $24.71 | 2025 | |
| Organon LLC | $24.30 | 2025 | Vtama |
| Celgene Corporation | $22.59 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $15.43 | 2019 | |
| Merck Sharp & Dohme LLC | $13.11 | 2019 | |
| Vyne Pharmaceuticals INC. | $11.79 | 2020 | |
| Prugen, INC. Pharmaceuticals | $8.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Volkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.